Descriptive Immunogenicity of 2 Doses of Pneumococcal 7-valent Conjugate Vaccine (Prevenar, Wyeth Lederle) Followed by Pneumococcal Polysaccharide Vaccine (Pneumovax Aventis Pasteur MSD) in Ataxia-telangiectasia Patients.
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary) ; Pneumococcal vaccine (Primary)
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- 17 Mar 2010 Planned initiation date changed from 1 Feb 2010 to 1 Mar 2010 as reported by ClinicalTrials.gov.
- 03 Mar 2010 New trial record